benzoxepins - CISMeF

Preferred Label : benzoxepins;

Is substance : O;

Détails

Origin ID

D001584;

UMLS CUI

C0005087;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Benzoxepin (substance) [SNOMED CT concept]
Record concept(s)
- benzoxepins [MeSH concept]
Related MeSH Supplementary Concept(s)
- (3-(chloromethylene)-2,3-dihydro-1-benzoxepin-7-yl)methanol [MeSH Supplementary Concept]
- (3S)-2,3-dihydro-3-(4-hydroxyphenyl)-1-benzoxepin-8-ol [MeSH Supplementary Concept]
- (3S)-2,3-dihydro-3-(4-hydroxyphenyl)-8-methoxy-1-benzoxepin-7-ol [MeSH Supplementary Concept]
- 1-(3-chloromethylene-2,3-dihydro-1-benzoxepin-7-yl)ethanone [MeSH Supplementary Concept]
- 10,11-dihydrodibenzo(b,f)oxepine-4-carboxamide [MeSH Supplementary Concept]
- 12-benzyloxy-4-(4-carboxyphenyl)-2,3,13-trioxatricyclo(7.2.2.0(1,7))tridecane [MeSH Supplementary Concept]
- 2,3,4,5-tetrahydro-2,7-dihydroxy-5,8,10,10-tetramethyl-2,5-methano-1- benzoxepin [MeSH Supplementary Concept]
- 3-(chloromethylene)-2,3-dihydro-1-benzoxepine-7-carbaldehyde [MeSH Supplementary Concept]
- 4-(4,10-dihydro-10-oxothieno(3,2-c)(1)-benzoxepin-8-yl)butanol [MeSH Supplementary Concept]
- 4-(4,10-dihydro-10-oxothieno(3,2-c)(1)benzoxepin-8-yl)butyric acid [MeSH Supplementary Concept]
- 5-((2-(diethylamino)ethyl)amino)-7-methoxy-5,11-dihydro(1)benzoxepino(3,4-b)pyridine [MeSH Supplementary Concept]
- 5-(3-dimethylamino propyliden)-benzofuro(2,3-c)benzoxepin-1 [MeSH Supplementary Concept]
- 5-amino-2,5-dihydro-1-benzoxepine [MeSH Supplementary Concept]
- 5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-3H,15H-oxepino(3',4'-6,7)indolizino(1,2-b)quinoline-3,15-dione [MeSH Supplementary Concept]
- 7-isopentyl-2H-benzo(b)(1,4)dioxepin-7(4H)-one [MeSH Supplementary Concept]
- 8-chloro-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-4,5-dihydrobenzo-1H-6-oxa-cyclohepta(1,2-c)pyrazole-3-carboxamide [MeSH Supplementary Concept]
- GDC-0326 [MeSH Supplementary Concept]
- GST-HG131 [MeSH Supplementary Concept]
- HSR 609 [MeSH Supplementary Concept]
- KW 3635 [MeSH Supplementary Concept]
- KW 5805 [MeSH Supplementary Concept]
- MLN3897 [MeSH Supplementary Concept]
- N-(3-(1-(10-methoxy-6H-benzo(c)(1)benzoxepin-11-ylidene)propyl)phenyl)methanesulfonamide [MeSH Supplementary Concept]
- argopsin [MeSH Supplementary Concept]
- arugosin C [MeSH Supplementary Concept]
- arugosin F [MeSH Supplementary Concept]
- benzophomepsin A [MeSH Supplementary Concept]
- bulbophylol-B [MeSH Supplementary Concept]
- calone [MeSH Supplementary Concept]
- decahydro-3-(4-carboxyphenyl)-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin [MeSH Supplementary Concept]
- dihydrobenzodioxepine cymserine [MeSH Supplementary Concept]
- empetroxepin A [MeSH Supplementary Concept]
- empetroxepin B [MeSH Supplementary Concept]
- exepanol [MeSH Supplementary Concept]
- ichangensin [MeSH Supplementary Concept]
- koninginin C [MeSH Supplementary Concept]
- nomilin [MeSH Supplementary Concept]
- obacunone [MeSH Supplementary Concept]
- oxeglitazar [MeSH Supplementary Concept]
- oxetorone [MeSH Supplementary Concept]
- pannarin [MeSH Supplementary Concept]
- paucinervin A [MeSH Supplementary Concept]
- pestalachloride B [MeSH Supplementary Concept]
- pestalospirane A [MeSH Supplementary Concept]
- pestalospirane B [MeSH Supplementary Concept]
- polycephalone A [MeSH Supplementary Concept]
- polycephalone B [MeSH Supplementary Concept]
- psoromic acid [MeSH Supplementary Concept]
- xylarinol A [MeSH Supplementary Concept]
- xylarinol B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients